D-0356-2025 Class II Ongoing
FDA drug recall D-0356-2025 was initiated by Somerset Therapeutics Private Limited on Mar 21, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Media fill with bacterial contamination The recall status is ongoing. Affected quantity: 4956 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 16, 2025
- Initiation Date
- Mar 21, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4956 vials
Product description
Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41
Reason for recall
Lack of Assurance of Sterility: Media fill with bacterial contamination
Distribution pattern
U.S. Nationwide
Code information
A240467B, exp. date 07/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0356-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026